Table 1 Population characteristics. Results expressed in numbers (percentages) except *median and interquartile interval [1st–3rd]. IAI intraabdominal infection
Variables | All IAI with Enterococcus spp. (n = 76) |
|---|---|
Age (years)* | 71.7 [59.0–78.1] |
Gender (M/F) | 43/33 |
Day 0 SAPS score* | 48 [37–57] |
Immunocompromised status | 20 (26.3%) |
Hospital admission-IAI time* | 8 [2–18] |
ICU admission-IAI time* | 1 [1–4] |
IAI diagnosis-surgery time | 0 [0–0] |
E. faecium | 28 (36.8%) |
E. faecalis | 46 (60.5%) |
Other Enterococcus spp. | 9 (11.8%) |
ICU acquired | 24 (31.6%) |
Nosocomial | 68 (89.5%) |
Postoperative | 53 (69.7%) |
Enterococcal bacteremia | 4 (5.3%) |
Septic shock at time of IAI diagnosis | 53 (69.7%) |
Source control | |
Surgery | 74 (97.4%) |
Percutaneous drainage | 2 (2.6%) |
IAI anatomical origin | |
Colon | 32 (42.7%) |
Small intestine | 19 (25.3%) |
Hepatobiliary | 12 (16%) |
Gastroduodenal | 8 (10.7%) |
Pathophysiology of IAI | |
Perforation | 22 (28.9%) |
Intraabdominal abscess | 27 (35.5%) |
Fistula | 26 (34.2%) |
Necrosis | 19 (25.0%) |
Surgical complications | 35 (46.1%) |
Intraabdominal abscess | 20 (26.3%) |
Wound infection | 19 (25.0%) |
Fistula | 8 (10.5%) |
Suture line disruption | 2 (2.6%) |
Evisceration | 1 (1.3%) |
Relaparotomy or percutaneous drainage at day 30 | 23 (30.3%) |
IAI-relaparotomy or IAI-percutaneous drainage time (days)* | 10 [6–20] |
Tertiary peritonitis | 16 (21.3%). |
Postoperative infectious complications at day 30 | 24 (31.6%) |
Septic shock at day 30 | 44 (57.9%) |
Mortality at day 30 | 17 (22.4%) |